Raphael Pharmaceutical Inc. Stock
Stocks
RAPH
US27785B2088
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
18:53:26 28/07/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.400 USD | -.--% |
|
-.--% | - |
| 08-14 | Raphael Pharmaceutical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 07-17 | Raphael Pharmaceutical Inc. Announces Board Resignations | CI |
| Market Cap | 28.25M 25.09M 23.46M 21.38M 40.25M 2.72B 40.81M 284M 110M 1.39B 106M 104M 4.45B | P/E 2024 |
-3.2x | P/E 2025 | -21.4x |
|---|---|---|---|---|---|
| Enterprise Value | 28.24M 25.08M 23.45M 21.37M 40.24M 2.72B 40.79M 284M 110M 1.38B 106M 104M 4.45B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
53.88% | Yield 2024 * |
-
| Yield 2025 | - |
| Current year | 0.05 |  | 1.4 |
| 1 year | 0.04 | | 1.4 |
| 3 years | 0.04 | | 1.65 |
| 5 years | 0.04 | | 2.5 |
| 10 years | 0.04 | | 2.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Shlomo Pilo
CEO | Chief Executive Officer | 73 | 14/05/2021 |
Shalom Tadelis
DFI | Director of Finance/CFO | 58 | 16/07/2026 |
| Chief Tech/Sci/R&D Officer | 53 | 27/09/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Shlomo Pilo
CHM | Chairman | 73 | 30/06/2026 |
Zvi Laufer
BRD | Director/Board Member | 74 | 07/08/2025 |
Shalom Tadelis
BRD | Director/Board Member | 58 | 16/07/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/20/25 A | Option | Chief Technology Officer | 700,000 | 3.5666% | ||
| 3/5/25 A | Free | Chairman | 600,000 | 3.2083% | ||
| 3/2/25 A | Free | Chief Executive Officer | 300,000 | 1.6042% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | +250.00% | +36.47% | 28.25M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.41B | |
| -0.93% | -1.35% | +24.67% | +78.54% | 59.26B | |
| +1.18% | -0.70% | +4.20% | +34.41% | 47.14B | |
| -3.02% | -5.20% | +27.94% | +32.51% | 42.91B | |
| +0.31% | +3.02% | +348.95% | +643.82% | 44.13B | |
| -1.96% | -0.33% | +7.04% | +99.46% | 40.79B | |
| +3.32% | +3.49% | +10.10% | +51.23% | 30.77B | |
| -2.68% | +2.92% | +29.63% | +22.72% | 29.31B | |
| -4.86% | -10.66% | -26.27% | +330.06% | 23.71B | |
| Average | -0.45% | -0.47% | +72.56% | +142.34% | 39.25B | |
| Weighted average by Cap. | +0.06% | -0.32% | +58.05% | +145.79% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.52M -1.35M -1.26M -1.15M -2.16M -146M -2.19M -15.26M -5.91M -74.48M -5.7M -5.58M -239M | -1.28M -1.14M -1.06M -968K -1.82M -123M -1.85M -12.85M -4.98M -62.71M -4.8M -4.7M -201M |
| Net Debt | 22K 19.54K 18.27K 16.65K 31.35K 2.12M 31.78K 221K 85.58K 1.08M 82.6K 80.81K 3.46M | -11K -9.77K -9.14K -8.33K -15.68K -1.06M -15.89K -111K -42.79K -539K -41.3K -40.4K -1.73M |
Employees
-
- Stock Market
- Stocks
- RAPH Stock
Select your edition
All financial news and data tailored to specific country editions
